Authors


Sneha Gajarla, BS

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.


Anushka M. Raj, BS

Latest:

Patients with higher preoperative measurements of angle kappa and angle alpha may experience blurry vision, dry eyes following cataract surgery

Anushka M. Raj, BS, second year medical student at the University of Oklahoma’s Dean McGee Eye Institute, presents "Inter-Device Measurement Reliability of Angle Kappa and Angle Alpha, Devices and Instruments" during ASCRS.


Hamza Memon

Latest:

Unlocking health mysteries

Researchers find a strong link between Alzheimer's disease and retinal thinning




Seth Pantanelli, MD

Latest:

Key Features of Some of the Latest Monofocal Aspheric IOLs

Seth Pantanelli, MD discusses the landscape of monofocal aspheric intraocular lenses (IOLs) and how he caters treatment options to each patient.


Jason Handza, DO

Latest:

Electronic health records: Moving beyond 'just a requirement'

Cutting-edge solutions are emerging in healthcare that streamline data capture through a user-friendly interface, leading to an increase in quality and accuracy of data collection while freeing physicians to spend more time with patients.


Denise Visco, MD, MBA

Latest:

Takeaway points from patient case #2

Denise Visco, MD, MBA, discusses takeaway points from patient case #2 for post-operative inflammation management for routine cataract surgery.


Jennifer Dunnigan, BS

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.



George N. Magrath, MD, MBA, MS

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


Ronald Frenkel, MD

Latest:

Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews interactive learning and innovation amid winter fun

Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, all set against the backdrop of Snowmass, Colorado.


Roy Schwartz, MD, PhD

Latest:

Unveiling genetic distinctions between reticular pseudodrusen and drusen

Insights from a genome-wide association study identify novel genetic loci


Robert T. Chang, MD

Latest:

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Robert T. Chang, MD, from Stanford University discusses how large language models are transforming ophthalmology by enhancing patient communication, documentation, and education, while also addressing ethical considerations and potential future applications in glaucoma care.


Blake K. Williamson, MD, MPH, MS

Latest:

Patient Case #2 Initial Impressions

Blake K Williamson MD, MPH, MS, discussed initial impressions of a female patient with high myopia and astigmatism who is an ideal candidate for phakic IOL implant.


Manuele Michelessi, MD

Latest:

Pivotal study data drive glaucoma patient treatment decisions

Two trials examine factors affecting the risk of disease.


Ngoc Pham, MBA

Latest:

Providing comprehensive eye care for diabetic patients in southern Vietnam

Community-based eye care is one of Orbis’s top priorities in the country.



Sumit Sharma, MD, FASRS

Latest:

Final Thoughts on Case Presentations and Advanced Therapies

Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.


Michael J. Shumski, MD, MSE

Latest:

Is office-based surgery a harbinger of things to come for ophthalmology?

One practice’s experience with office-based surgery validates peer-reviewed study.


Greg Pierce

Latest:

Creating a positive patient financial journey for refractive error procedures

Clear communication, transparent priceing, options are key to positive experience


Ramin Tadayoni, MD, PhD

Latest:

Quest continues for topical treatments for posterior segment

Novel treatments are now shifting paradigm in care of retinal diseases.


Bela Parekh

Latest:

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

Balancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.


Aleksandra Rachitskaya, MD

Latest:

Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases

Panelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.


Marc D. de Smet, MD, PhD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Jennifer K. Dunnigan

Latest:

Unlocking health mysteries

Researchers find a strong link between Alzheimer's disease and retinal thinning


Shan Lin, MD

Latest:

New and upcoming MIGS with Shan Lin, MD

Shan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers as they work to preserve vision and work towards a better future for glaucoma treatment options.


Alessandro Berni, MD

Latest:

Updated guidelines enhance choriocapillaris imaging in AMD with SS-OCTA

Compensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts


Shlomo Melamed, MD

Latest:

Lessons from the Togo Glaucoma Project

SLT shows promise as treatment for millions of Africans with glaucoma.


Katherine Talcott, MD

Latest:

A Case of a Geographic Atrophy Patient Needing Low Vision Rehabilitation

An ophthalmologist presents the case of a 76-year-old woman who has geographic atrophy and progressively worsening vision in her right eye, with a history of macular macrovessel and choroidal hemangioma.

© 2025 MJH Life Sciences

All rights reserved.